Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 17 studies | 30% ± 11% | |
glutamatergic neuron | 6 studies | 44% ± 24% | |
microglial cell | 6 studies | 24% ± 6% | |
GABAergic neuron | 5 studies | 47% ± 20% | |
macrophage | 5 studies | 30% ± 12% | |
oligodendrocyte | 5 studies | 22% ± 4% | |
endothelial cell | 4 studies | 22% ± 3% | |
astrocyte | 4 studies | 32% ± 4% | |
oligodendrocyte precursor cell | 4 studies | 28% ± 6% | |
myeloid cell | 3 studies | 20% ± 3% | |
interneuron | 3 studies | 50% ± 20% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 39% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2850.94 | 1445 / 1445 | 100% | 6.97 | 183 / 183 |
brain | 100% | 4120.40 | 2641 / 2642 | 99% | 7.83 | 697 / 705 |
lung | 100% | 3285.07 | 578 / 578 | 97% | 4.74 | 1123 / 1155 |
skin | 100% | 2070.65 | 1808 / 1809 | 97% | 4.95 | 458 / 472 |
stomach | 100% | 1804.48 | 359 / 359 | 97% | 3.96 | 277 / 286 |
intestine | 100% | 2873.14 | 966 / 966 | 96% | 3.05 | 505 / 527 |
breast | 100% | 2101.22 | 459 / 459 | 94% | 4.81 | 1052 / 1118 |
pancreas | 99% | 1459.51 | 326 / 328 | 94% | 2.93 | 167 / 178 |
ovary | 100% | 2793.18 | 180 / 180 | 90% | 3.77 | 389 / 430 |
kidney | 100% | 2004.26 | 89 / 89 | 90% | 3.19 | 815 / 901 |
bladder | 100% | 2403.71 | 21 / 21 | 89% | 2.85 | 450 / 504 |
thymus | 100% | 2143.46 | 652 / 653 | 89% | 3.45 | 538 / 605 |
uterus | 100% | 2742.52 | 170 / 170 | 87% | 3.27 | 401 / 459 |
prostate | 100% | 2272.60 | 244 / 245 | 86% | 2.47 | 430 / 502 |
adrenal gland | 100% | 2012.22 | 258 / 258 | 67% | 1.70 | 155 / 230 |
liver | 86% | 797.58 | 194 / 226 | 35% | 0.67 | 144 / 406 |
spleen | 100% | 5754.75 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2603.16 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 2242.92 | 1203 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 3612.97 | 912 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 1784.29 | 845 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 1398.61 | 783 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 5.13 | 40 / 45 |
eye | 0% | 0 | 0 / 0 | 88% | 2.55 | 70 / 80 |
lymph node | 0% | 0 | 0 / 0 | 86% | 6.27 | 25 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010507 | Biological process | negative regulation of autophagy |
GO_0045806 | Biological process | negative regulation of endocytosis |
GO_0002376 | Biological process | immune system process |
GO_0006914 | Biological process | autophagy |
GO_1901097 | Biological process | negative regulation of autophagosome maturation |
GO_0071985 | Biological process | multivesicular body sorting pathway |
GO_0006909 | Biological process | phagocytosis |
GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005764 | Cellular component | lysosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005770 | Cellular component | late endosome |
GO_0005769 | Cellular component | early endosome |
GO_0141039 | Molecular function | phosphatidylinositol 3-kinase inhibitor activity |
GO_1901981 | Molecular function | phosphatidylinositol phosphate binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RUBCN |
Protein name | Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon) (Beclin-1 associated RUN domain containing protein) (Baron) Rubicon autophagy regulator KIAA0226 protein |
Synonyms | KIAA0226 |
Description | FUNCTION: Inhibits PIK3C3 activity; under basal conditions negatively regulates PI3K complex II (PI3KC3-C2) function in autophagy. Negatively regulates endosome maturation and degradative endocytic trafficking and impairs autophagosome maturation process. Can sequester UVRAG from association with a class C Vps complex (possibly the HOPS complex) and negatively regulates Rab7 activation . .; FUNCTION: Involved in regulation of pathogen-specific host defense of activated macrophages. Following bacterial infection promotes NADH oxidase activity by association with CYBA thereby affecting TLR2 signaling and probably other TLR-NOX pathways. Stabilizes the CYBA:CYBB NADPH oxidase heterodimer, increases its association with TLR2 and its phagosome trafficking to induce antimicrobial burst of ROS and production of inflammatory cytokines . Following fungal or viral infection (implicating CLEC7A (dectin-1)-mediated myeloid cell activation or RIGI-dependent sensing of RNA viruses) negatively regulates pro-inflammatory cytokine production by association with CARD9 and sequestering it from signaling complexes . . |
Accessions | ENST00000296343.10 [Q92622-1] ENST00000415452.5 H7C3H3 ENST00000707076.1 ENST00000447048.1 ENST00000474214.2 A0A9L9PY84 ENST00000449205.1 ENST00000273582.9 [Q92622-2] H0Y6E6 A0A096LNI3 Q8N4U6 Q92622 ENST00000413360.5 H7C357 E9PEM3 |